News

A San Francisco attorney who narrowly avoided being disbarred because of fraud allegations in 2018 has been stripped of his ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
A 62-year-old Queensland man is facing charges in Sydney over his alleged role in a spiritual “blessing scam” that targeted ...
E-bike battery malfunction leads to fire and first NYC battery-related death in 2025, trapping 76-year-old woman in a Queens pizzeria.